F-box蛋白 FBXO32 无处不在并稳定D型环林,以驱动癌症的进展
Feng Li1,2,3, Hongqiang Yu1, Yujun Zhang1
1Key Laboratory of Hepatobiliary and Pancreatic Surgery, Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Nature communications
|April 30, 2025
概括
这种E3泛基因酶FBXO32 (atrogin-1) 稳定了环林D蛋白,促进了癌症. 针对这种FBXO32-cyclin D相互作用可能会改善癌症治疗,包括CDK4/6抑制剂.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- D型环林是G1/S细胞周期过渡的关键调节者.
- 异常的环林D表达与癌症的发展有关.
- 控制环林D蛋白循环的机制尚未完全理解.
研究的目的:
- 为了识别负责环林D周转的E3泛素连酶.
- 阐明FBXO32在调节循环D稳定性和癌症进展中的作用.
- 调查针对FBXO32-cyclin D轴的治疗潜力.
主要方法:
- 鉴定FBXO32为E3环林D的泛素结合酶.
- 在 Lysine 58 中分析FBXO32-介导的环素 D1 的泛基化.
- 研究GSK-3β在环林D1脱化和FBXO32相互作用中的作用.
- 在小鼠模型中评估FBXO32的促进瘤效应.
- FBXO32水平与患者预后的相关性.
- 在结合FBXO32抑制时评估palbociclib的疗效.
主要成果:
- FBXO32 (atrogin-1) 针对所有D型环林进行无处不在和稳定.
- FBXO32 特别催化了在 Lysine 58 处的 D1 环素的 Lysine 27 结合的多比基化.
- 通过GSK-3β无活化诱导的环素D1脱酸化增强了其与FBXO32.32的相互作用.
- FBXO32促进了小鼠的瘤生长,并与癌症预后不佳有关.
- 破坏FBXO32-cyclin D轴可以增强palbociclib的抗瘤功效.
结论:
- FBXO32通过K27相关的无化增强了环林D蛋白的稳定性.
- FBXO32有助于癌症的进展和对CDK4/6抑制剂的抵抗.
- 准FBXO32-cyclin D轴代表了癌症的潜在治疗策略.
相关概念视频
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Inhibition of Cdk Activity
4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K
Positive Regulator Molecules
5.2K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.2K
Negative Regulator Molecules
35.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.0K
MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
M-Cdk Drives Transition Into Mitosis
5.4K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.4K


